Results 51 to 60 of about 7,637,333 (353)

Dexamethasone for Chemotherapy‐Induced Nausea and Vomiting Prevention in Pediatric Patients: International Consensus

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background An international Delphi panel of experts developed consensus statements to delineate the circumstances where the risks of dexamethasone as an antiemetic do and do not outweigh its benefits. Procedure Experts in supportive care of pediatric patients were invited to participate.
Negar Shavandi   +20 more
wiley   +1 more source

Termination of life care agreement and the rights of successors: In the discrepancy between law and practice [PDF]

open access: yesPravni Zapisi, 2019
Recognizing the fact that various modalities of life care exist in contemporary legal practice, this paper encompasses the analysis and discussion about the possibilities of contract termination, and the rights of successors related to termination of the
Arsić Jelena, Stanivuk Bojan
doaj  

The essence and features of housing legal relations

open access: yesBulletin of Kharkiv National University of Internal Affairs, 2023
The analysis of scientific viewpoints of scholars on the interpretation of the concepts of “social relations”, “legal relations” and “housing legal relations” has been carried out, and the author's own definition for the latter has been proposed.
M. Ye. Vasylenko
doaj   +1 more source

Is Toufik Lounes another brick in the wall? The CJEU and the on-going shaping of the EU citizenship [PDF]

open access: yes, 2018
This Insight tackles a recent judgment of the CJEU, Toufik Lounes (Court of Justice, judgment of 14 November 2017, case C-165/16, Toufik Lounes v. Secretary of State for the Home Department), where the CJEU was asked to rule on the case of a EU national,
Gualco, Elena
core   +2 more sources

Clinical Insights Into Hypercalcemia of Malignancy in Childhood

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Hypercalcemia of malignancy (HCM) is a rare but life‐threatening metabolic emergency in children that occurs in less than 1% of pediatric cancer cases, with a reported incidence ranging from 0.4% to 1.0% across different studies. While it is observed in 10%–20% of adult malignancies, pediatric HCM remains relatively uncommon.
Hüseyin Anıl Korkmaz
wiley   +1 more source

Insurance from the potential risk A Comparative Study [PDF]

open access: yesالرافدین للحقوق, 2006
Insurance is increasingly important in our daily lives because it is no longer limited to some known forms such as life insurance or fire insurance, but other forms have spread to cover all aspects of economic and social activities, especially with ...
Israa Salih Dawod
doaj   +1 more source

Second Chance Act Fact Sheet [PDF]

open access: yes, 2013
Signed into law on April 9, 2008, the Second Chance Act (P.L. 110-199) is designed to positively impact the life outcomes of individuals transitioning into society after experiencing incarceration. The Second Chance Act authorizes grants to state, local,

core  

Survival Outcomes and Complications Among Canadian Children With Retinoblastoma: A Population‐Based Report From CYP‐C

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Retinoblastoma (RB) is the most common pediatric ocular cancer, yet population‐based data on survival and risk factors remain limited. This study aimed to describe survival in a large national RB cohort and identify predictors of death and complications.
Samuel Sassine   +14 more
wiley   +1 more source

Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate selumetinib exposure using therapeutic drug monitoring (TDM) in pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PN), assess interpatient pharmacokinetic variability, and explore the relationship between drug exposure, clinical response, and adverse effects.
Janka Kovács   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy